Anticardiolipin Antibodies in COVID-19 – Report of Three Cases

1. Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020;127:104370.10.1016/j.jcv.2020.104370719464832344321Search in Google Scholar

2. Scialpi M, Scialp S, Piscioli I, et al. Pulmonary thromboembolism in criticall ill COVID-19 patients. Int J Infect Dis 2020 Apr 24.10.1016/j.ijid.2020.04.056718035232339717Search in Google Scholar

3. WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. 2020.Search in Google Scholar

4. Violi F, Pastori D, Cangemi R, et al. Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge. Thromb Haemost Published Online First: 2020 Apr 29.10.1055/s-0040-1710317729529032349133Search in Google Scholar

5. Gris J, Quéré I, Pérez-Martin A, et al. Uncertainties on the prognostic value of D-dimers in COVID-19 patients. J Thromb Haemost 2020 Apr 28.10.1111/jth.14876726723732344457Search in Google Scholar

6. Bowles L, Platton S, Yartey N, et al. Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19. N Engl J Med 2020 May 5.10.1056/NEJMc2013656721755532369280Search in Google Scholar

7. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295–306.10.1111/j.1538-7836.2006.01753.x16420554Search in Google Scholar

8. Caraiola S, Jurcu C, Dima A, et al. Antiphosphatidylethanolamine Antibodies and Deep Vein Thrombosis in Lupus Patients with Antiphospholipid Syndrome. Rev Rom Med Lab 2018;26:243–50.10.2478/rrlm-2018-0009Search in Google Scholar

9. Fan BE. Hematologic parameters in patients with COVID-19 infection. Am J Hematol 2020 Apr 27.10.1002/ajh.25847726747732339335Search in Google Scholar

10. Cattaneo M, Bertinato EM, Birocchi S, et al. Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? Thromb Haemost 2020 Apr 29.10.1055/s-0040-1712097751635632349132Search in Google Scholar

11. Vulliamy P, Jacob S, Davenport RA. Acute aorto-iliac and mesenteric arterial thromboses as presenting features of COVID-19. Br J Haematol 2020 Apr 30.10.1111/bjh.16760726761832353183Search in Google Scholar

12. Grillet F, Behr J, Calame P, et al. Acute Pulmonary Embolism Associated with COVID-19 Pneumonia Detected by Pulmonary CT Angiography. Radiology 2020; 201544.10.1148/radiol.2020201544Search in Google Scholar

13. Thachil J. What do monitoring platelet counts in COVID-19 teach us? J Thromb Haemost 2020:14879.10.1111/jth.14879Search in Google Scholar

14. Albu DE, Copotoiu M, Szmuk P, et al. Platelets and Infections Course notes. Rev Română Med Lab 2018;26 (4): 497-502.Search in Google Scholar

15. Mendoza-Pinto C, García-Carrasco M, Cervera R. Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant). Curr Rheumatol Rep 2018;20(10):62.10.1007/s11926-018-0773-xSearch in Google Scholar

16. McNeil HP, Chesterman CN, Krilis SA. Immunology and Clinical Importance of Antiphospholipid Antibodies. Adv Immunol 1991;49:193–280.10.1016/S0065-2776(08)60777-4Search in Google Scholar

17. Kravvariti E, Koutsogianni A, Samoli E, et al. The effect of hydroxychloroquine on thrombosis prevention and antiphospholipid antibody levels in primary antiphospholipid syndrome: A pilot open label randomized prospective study. Autoimmun Rev 2020;19(4):102491.1810.1016/j.autrev.2020.10249132084592Search in Google Scholar

18. Sarma P, Kaur H, Kumar H, et al. Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis. J Med Virol 2020 Apr 16.10.1002/jmv.25898726214432297988Search in Google Scholar